Evidence map›Paper›PMID 38375344›Full record

ArticleEuropean urology open science2024

Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial.

Thomas van Doeveren, Sebastiaan Remmers, Vera Atema, Roderick C N van den Bergh, Egbert R Boevé, Erik B Cornel, Antoine G van der Heijden, Kees Hendricksen, Evelyne C C Cauberg, Rens A L Jacobs and 14 more

Abstract read
In one paragraph

Article in European urology open science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Thomas van DoeverenDepartment of Urology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Sebastiaan RemmersDepartment of Urology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Vera AtemaDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
Roderick C N van den BerghDepartment of Urology, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
Egbert R BoevéDepartment of Urology, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands.
Erik B CornelDepartment of Urology, Ziekenhuis Groep Twente, Hengelo, The Netherlands.
Antoine G van der HeijdenDepartment of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kees HendricksenDepartment of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Evelyne C C CaubergDepartment of Urology, Isala Medical Center, Zwolle, The Netherlands.
Rens A L JacobsDepartment of Urology, Zuyderland Medical Center, Heerlen and Sittard, The Netherlands.
Bin K KroonDepartment of Urology, Rijnstate Medical Center, Arnhem, The Netherlands.
Annemarie M LeliveldDepartment of Urology, University Medical Center Groningen, Groningen, The Netherlands.
Richard P MeijerDepartment of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
Bob MerksDepartment of Urology, Haaglanden Medical Center, Leidschendam, The Netherlands.
Jorg R OddensDepartment of Urology, AmsterdamUMC, University of Amsterdam, Amsterdam, The Netherlands.
Luc RoelofsDepartment of Urology, Treant Zorggroep, Emmen, The Netherlands.
Diederik M SomfordDepartment of Urology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Peter de VriesDepartment of Urology, Treant Zorggroep, Emmen, The Netherlands.
Bart WijsmanDepartment of Urology, Elisabeth-Tweesteden Medical Center, Tilburg, The Netherlands.
Willemijn A K M WindtDepartment of Urology, Martini Ziekenhuis, Groningen, The Netherlands.
Peter J ZwaanDepartment of Urology, Gelre Ziekenhuis, Apeldoorn, The Netherlands.
Pim J van LeeuwenDepartment of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Joost L BoormansDepartment of Urology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Katja K H AbenDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective: The possible negative impact of radical surgery on patients' health-related quality of life (HRQoL) plays an important role in preoperative counseling. Here, we analyzed the HRQoL of patients treated for upper urinary tract urothelial carcinoma (UTUC) in the context of a single-arm phase 2 multicenter study, in which the safety and efficacy of a single preoperative intravesical instillation with mitomycin C were investigated. Our objective was to investigate early changes in HRQoL in patients undergoing radical surgery for UTUC and identify factors associated with these outcomes. Methods: Patients with pTanyN0-1M0 UTUC were prospectively included. HRQoL was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30) questionnaire at baseline, and at 1 and 3 mo after surgery. A linear mixed model was used to evaluate the changes in HRQoL over time and identify the variables associated with these outcomes. The clinical effect size was used to assess the clinical impact and level of perceptibility of HRQoL changes for clinicians and/or patients based on given thresholds. Key findings and limitations: Between 2017 and 2020, 186 patients were included. At baseline, 1 mo after surgery, and 3 mo after surgery, response rates were 91%, 84%, and 78%, respectively. One month after surgery, a statistically significant and clinically relevant deterioration was observed in physical, role, and social functioning, and for the included symptom scales: constipation, fatigue, and pain. An improvement in emotional functioning was observed. At 3 mo, HRQoL returned to baseline levels, except emotional functioning, which improved at 1 mo and persisted to be better than that before surgery. Age >70 yr was associated with worse physical functioning, but better social and emotional functioning. Male patients reported better emotional functioning than females. Postoperative complications were negatively associated with social functioning. Conclusions and clinical implications: UTUC patients treated with radical surgery experienced a significant, albeit temporary, decline in HRQoL. Three months following surgery, HRQoL outcomes returned to baseline levels. This information can be used to counsel UTUC patients before undergoing radical surgery and contextualize recovery after surgery. Patient summary: We investigated the changes in quality of life as reported by patients who underwent surgery for upper tract urothelial carcinoma (UTUC). We found that patients experienced a decline in quality of life 1 mo after surgery, but this was temporary, with full recovery of quality of life 3 mo after surgery. These findings can help doctors and other medical staff in counseling UTUC patients before undergoing radical surgery.

Indexed as

European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30Health-related quality of lifeRadical surgeryShort termUpper urinary tractUrothelial carcinoma

Identifiers

PMID38375344
PMCPMC10874848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.